Can-Fite BioPharma (CANF)
NYSE MKT:CANF
Holding CANF?
Track your performance easily

Can-Fite BioPharma (CANF) Cash flow

513 Followers

Can-Fite BioPharma Cash Flow

CANF's free cash flow for Q4 2023 was $―. For the 2023 fiscal year, CANF's free cash flow was decreased by $2.37M and operating cash flow was $―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
-$ -8.44M$ -10.80M$ -9.86M$ -12.06M$ -11.08M
Investing Cash Flow
-$ 498.00K$ 9.50M$ -14.51M$ -26.00K$ -3.00K
Financing Cash Flow
-$ 9.14M-$ 20.46M$ 20.38M$ 10.17M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-$ 4.28M$ 2.98M$ 4.39M$ 10.96M$ 2.70M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
---$ 18.00K$ 23.00K$ 29.00K
Issuance Of Capital Stock
-$ 9.14M---$ 10.17M
Issuance Of Debt
-----$ -34.00K
Repayment Of Debt
-----$ -34.00K
Free Cash Flow
-$ -8.44M$ -10.81M$ -9.87M$ -12.09M$ -11.09M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Can-Fite BioPharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis